Zhao TT. Follow-up survey on quality of life and influencing factors of patients after gynecological malignant tumor surgery. Xinjiang Medical University; 2019 (in Chinese).
Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–1075.
Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160–174.
Liu CL, Liu L, Zhang Y, et al. Prevalence and its associated psychological variables of symptoms of depression and anxiety among ovarian cancer patients in China: a cross-sectional study. Health Qual Life Outcomes. 2017;15:161.
Yang YL, Liu L, Wang Y, et al. The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis. BMC Cancer. 2013;13:393.
Linden W, Vodermaier A, Mackenzie R, et al. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141:343–351.
Di MVE, Letizia C, Martina B, et al. Coping mechanisms, psychological distress, and quality of life prior to cancer genetic counseling. Front Psychol. 2018;9:1218.
Tercyak KP, Lerman C, Peshkin BN, et al. Effects of coping style and brca1 and brca2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychol. 2001;20:217–222.
Stewart SL, Rim SH, Trivers KF. Summary and impact of ovarian cancer research and programmatic activities at the centers for disease control and prevention. J Womens Health. 2010;19: 1427–1432.
Fairley TL, Pollack LA, Moore AR, et al. Addressing cancer survivorship through public health: an update from the centers for disease control and prevention. J Womens Health, 2009;18: 1525–1531.
Price MA, Butow PN, Costa DSJ, et al. Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their caregiver. Med J Aust. 2010;193(suppl 5):52–57.
Yang YL, Liu L, Wang Y, et al. The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis. BMC Cancer. 2013;13:393.
Sam W, Philip P, Jessica M, et al. Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2015;5:7618.
Mielcarek P, Nowicka-Sauer K, Kozaka J. Anxiety and depression in patients with advanced ovarian cancer: a prospective study. J Psychosom Obstet Gynecol, 2016;37:11.
Hu H, Chen G. Prevalence of depression in Chinese patients with malignant tumor and its related factors. Chin J Clin Oncol Rehabil. 2015;22:636–637 (in Chinese).
Wang HQ, Ma YL, Li X. Investigation on anxiety, depression and coping styles for patients with bone tumour during chemotherapy. China Med Herald. 2014;11:112–115 (in Chinese).
Lutgendorf SK, Shinn E, Carter J, et al. Quality of life among long-term survivors of advanced stage ovarian cancer: a cross-sectional approach. Gynecol Oncol. 2017;146:101–108.
Yang YL, Liu L, Li MY, et al. Psychological disorders and psychosocial resources of patients with newly diagnosed bladder and kidney cancer: a cross-sectional study. PloS One. 2016;11:e0155607.
Wu HX, Zhong H, Xu YD, et al. Psychological and behavioral intervention improves the quality of life and mental health of patients suffering from differentiated thyroid cancer treated with postoperative radioactive iodine-131. Neuropsych Dis Treat. 2016;12:1055–1060.
Costa ALS, Heitkemper MM, Alencar GP, et al. Social support is a predictor of lower stress and higher quality of life and resilience in Brazilian patients with colorectal cancer. Cancer Nurs. 2016;40:1.
Wang XF, Hong LX. Influence of psychological intervention on the anxiety and depressive symptoms for patients with ovarian cancer in China: a meta-analysis. Mod Med J. 2014;42:248–252 (in Chinese).